Ascendis Pharma to Report First Quarter 2024 Financial Results and Provide Business Update on May 2, 2024

Core Viewpoint - Ascendis Pharma A/S is set to report its first quarter 2024 financial results and provide a business update on May 2, 2024, after U.S. market close, followed by a conference call and live webcast to discuss the results [1] Group 1 - Ascendis Pharma utilizes its innovative TransCon technology platform to develop new therapies aimed at improving patient outcomes [2] - The company is headquartered in Copenhagen, Denmark, with additional facilities in Europe and the United States [2] - Ascendis Pharma emphasizes its core values of Patients, Science, and Passion in its operations [2]